![Erica Whittaker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erica Whittaker
Directeur/Membre du Conseil chez
Neurona Therapeutics, Inc.
Profil
Erica Whittaker is currently a Director at Neurona Therapeutics, Inc. and a Director at StrideBio, Inc. She is also a Director at SpliceBio SL, UCB Ventures (Private Equity), Rinri Therapeutics Ltd., and Exevir Bio BV.
Previously, she worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith Ltd.
Postes actifs de Erica Whittaker
| Sociétés | Poste | Début |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Directeur/Membre du Conseil | 22/06/2021 |
UCB Ventures London
 UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01/10/2017 |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Directeur/Membre du Conseil | - |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Directeur/Membre du Conseil | 14/06/2018 |
Rinri Therapeutics Ltd.
 Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Directeur/Membre du Conseil | 01/02/2021 |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | - |
UCB Ventures (Private Equity)
 UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Directeur/Membre du Conseil | - |
Anciens postes connus de Erica Whittaker
| Sociétés | Poste | Fin |
|---|---|---|
Merrill Lynch, Pierce, Fenner & Smith Ltd.
 Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2009 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith Ltd.
Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Finance |
UCB Ventures London
UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Finance |
Rinri Therapeutics Ltd.
Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Commercial Services |
Exevir Bio BV
Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Health Technology |
